ReviewJournal of cardiovascular translational research2026
Traditional Chinese Medicine Targeting Ferroptosis in Cardiovascular Diseases: Advances and Perspectives.
Review in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation and redox imbalance, has recently garnered significant attention for its critical role in the pathogenesis of cardiovascular diseases (CVDs). Accumulating evidence suggests that ferroptosis contributes to a range of cardiovascular pathologies by disturbing iron homeostasis, promoting oxidative stress, and impairing mitochondrial function. Traditional Chinese medicine (TCM), with its multi-component and multi-target properties and relatively low toxicity, has shown unique therapeutic potential in modulating ferroptosis-related pathways. This review provides a comprehensive summary of the current understanding of ferroptosis in CVDs and highlights the mechanisms by which TCM and its bioactive constituents influence ferroptosis. We further discuss the therapeutic implications and translational challenges, aiming to provide novel insights into ferroptosis-targeted interventions for CVDs from the perspective of TCM.
Indexed as
Identifiers
41984309What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.